Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram versus placebo for irritable bowel syndrome with panic disorder
NL-OMON43726Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in irritable bowel syndrome (IBS) and panic disorder comparing Escitalopram with Placebo (2 arms). Primary endpoint: Gastrointestinal Symptom Rating Scale. Started Jan 2012; status: active, not recruiting.
02
Drugs
escitalopram
03
Conditions
irritable bowel syndrome (IBS)panic disorder
Beyond the preview
Go deeper on NL-OMON43726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43726.